Literature DB >> 16356928

Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing.

Anne Halenius1, Frank Momburg, Henrike Reinhard, Dagmar Bauer, Mario Lobigs, Hartmut Hengel.   

Abstract

The endoplasmic reticulum-resident human cytomegalovirus glycoprotein US6 (gpUS6) inhibits peptide translocation by the transporter associated with antigen processing (TAP) to prevent loading of major histocompatibility complex class I molecules and antigen presentation to CD8+ T cells. TAP is formed by two subunits, TAP1 and TAP2, each containing one multispanning transmembrane domain (TMD) and a cytosolic nucleotide binding domain. Here we reported that the blockade of TAP by gpUS6 is species-restricted, i.e. gpUS6 inhibits human TAP but not rat TAP. Co-expression of human and rat subunits of TAP demonstrates independent binding of gpUS6 to human TAP1 and TAP2, whereas gpUS6 does not bind to rat TAP subunits. gpUS6 associates with preformed TAP1/2 heterodimers but not with unassembled TAP subunits. To locate domains of TAP required for gpUS6 binding and function, we took advantage of reciprocal human/rat intrachain TAP chimeras. Each TAP subunit forms two contact sites within its TMD interacting with gpUS6. The dominant gpUS6-binding site on TAP2 maps to an N-terminal loop, whereas inhibition of peptide transport is mediated by a C-terminal loop of the TMD. For TAP1, two gpUS6 binding domains are formed by loops of the C-terminal TMD. The domain required for TAP inactivation is built by a distal loop of the C-terminal TMD, indicating a topology of TAP1 comprising 10 endoplasmic reticulum transmembrane segments. By forming multimeric complexes, gpUS6 reaches the distant target domains to arrest peptide transport. The data revealed a nonanalogous multipolar bridging of the TAP TMDs by gpUS6.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356928     DOI: 10.1074/jbc.M510223200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

Review 1.  MHC class I antigen presentation: learning from viral evasion strategies.

Authors:  Ted H Hansen; Marlene Bouvier
Journal:  Nat Rev Immunol       Date:  2009-07       Impact factor: 53.106

Review 2.  Viral proteins interfering with antigen presentation target the major histocompatibility complex class I peptide-loading complex.

Authors:  Gustav Røder; Linda Geironson; Iain Bressendorff; Kajsa Paulsson
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

3.  The cytoplasmic domain of rhesus cytomegalovirus Rh178 interrupts translation of major histocompatibility class I leader peptide-containing proteins prior to translocation.

Authors:  Rebecca Richards; Isabel Scholz; Colin Powers; William R Skach; Klaus Früh
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

4.  Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other.

Authors:  Abdelrahman Said; Walid Azab; Armando Damiani; Nikolaus Osterrieder
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

5.  Inhibition of antigen presentation during AAV gene therapy using virus peptides.

Authors:  Wenwei Shao; Xiaojing Chen; Richard J Samulski; Matthew L Hirsch; Chengwen Li
Journal:  Hum Mol Genet       Date:  2018-02-15       Impact factor: 6.150

Review 6.  Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.

Authors:  Joana Loureiro; Hidde L Ploegh
Journal:  Adv Immunol       Date:  2006       Impact factor: 3.543

7.  The capacity of UL49.5 proteins to inhibit TAP is widely distributed among members of the genus Varicellovirus.

Authors:  Marieke C Verweij; Andrea D Lipinska; Danijela Koppers-Lalic; Wouter F van Leeuwen; Jeffrey I Cohen; Paul R Kinchington; Ilhem Messaoudi; Krystyna Bienkowska-Szewczyk; Maaike E Ressing; Frans A M Rijsewijk; Emmanuel J H J Wiertz
Journal:  J Virol       Date:  2010-12-15       Impact factor: 5.103

8.  Human cytomegalovirus disrupts the major histocompatibility complex class I peptide-loading complex and inhibits tapasin gene transcription.

Authors:  Anne Halenius; Sebastian Hauka; Lars Dölken; Jan Stindt; Henrike Reinhard; Constanze Wiek; Helmut Hanenberg; Ulrich H Koszinowski; Frank Momburg; Hartmut Hengel
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

9.  Structural and Functional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6.

Authors:  Gillian E Dugan; Eric W Hewitt
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

10.  Dynamics of major histocompatibility complex class I association with the human peptide-loading complex.

Authors:  Michaela S Panter; Ankur Jain; Ralf M Leonhardt; Taekjip Ha; Peter Cresswell
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.